0
4basebio PLC Banner Image

4basebio PLC

  • Ticker 4BB
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
4basebio PLC Logo Image
  • 11-50 Employees
  • Based in Cambridge, England
4basebio PLC is developing next generation gene therapy technologies and solutions. 4basebio started with a focus on the manufacture of synthetic DNA for use in gene therapies; their synthetic DNA has clear safety, efficacy, and cost benefits over current plasmid DNA. Their near-term objective is the development of Good Manufacturing Practice (“GMP”) grade synthetic DNA as a key milestoneMore in the commercialisation of this core technology.
REPORT RATINGS
4.8 / 5.0 (97)

4basebio PLC reports have an aggregate usefulness score of 4.8 based on 97 reviews.

4basebio PLC

Most Recent Annual Report

4basebio PLC
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

4basebio PLC Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!